BRIEF published on 04/02/2026 at 04:05, 2 months 3 days ago Aperçu des résultats financiers de MedMira Inc. pour le deuxième trimestre de l'exercice 2026 Perte Nette Résultats Financiers De MedMira Frais D'exploitation Partenariat McKesson Chiffre D'affaires Du Deuxième Trimestre De L'exercice 2026
BRIEF published on 04/02/2026 at 04:05, 2 months 3 days ago MedMira Inc. Q2 FY2026 Financial Results Overview Net Loss Operating Expenses MedMira Financial Results McKesson Partnership Q2 FY2026 Revenue
PRESS RELEASE published on 04/02/2026 at 04:00, 2 months 3 days ago MedMira Reports Second Quarter Results FY2025 MedMira Inc. reports partnership with McKesson, financial results and progress on new tests. The company aims to expand market reach and improve sales Financial Results Clinical Trials MedMira Inc. RVF Technology McKesson Partnership
BRIEF published on 12/31/2025 at 02:05, 5 months 6 days ago MedMira Reports First Quarter Results for FY2026 Health Canada MedMira Q1 Financials MiROQ Technology Reveal® TP
BRIEF published on 12/31/2025 at 02:05, 5 months 6 days ago MedMira publie ses résultats du premier trimestre de l'exercice 2026 MedMira Santé Canada Technologie MiROQ Reveal® TP Résultats Financiers Du T1
PRESS RELEASE published on 12/31/2025 at 02:00, 5 months 6 days ago MedMira Reports First Quarter Results FY2026 MedMira Inc. reports Health Canada approval for Reveal® TP (Syphilis) rapid test, progress in clinical trials, and financial results for Q1 FY2026 Financial Results Clinical Trials MedMira Inc. Health Canada Approval Reveal® TP
BRIEF published on 11/29/2025 at 03:05, 6 months 6 days ago MedMira Releases FY2025 Financial Performance Financial Results MedMira Diagnostic Tests FY2025 MiROQ Technology
BRIEF published on 11/29/2025 at 03:05, 6 months 6 days ago MedMira publie ses résultats financiers pour l'exercice 2025 Résultats Financiers MedMira Exercice 2025 Tests Diagnostiques Technologie MiROQ
PRESS RELEASE published on 11/29/2025 at 03:00, 6 months 6 days ago MedMira Reports FY2025 Fourth Quarter and Year End Financial Results MedMira Inc. reports on financial results for FY2025, including product launches, clinical trials, and commercial advancements. Details on revenue, profit, loss, and balance sheet highlights are provided Financial Results Clinical Trials MedMira Inc. Product Launches Commercial Advancements
BRIEF published on 08/26/2025 at 22:48, 9 months 10 days ago Santé Canada approuve le test rapide de dépistage de la syphilis de MedMira Syphilis MedMira Santé Canada Tests Rapides Maladie Infectieuse
Published on 06/06/2026 at 00:00, 2 hours 40 minutes ago Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
Published on 06/05/2026 at 17:00, 9 hours 40 minutes ago Silver Spruce Resources Inc. Provides an Update on the Jackie Project Acquisition
Published on 06/05/2026 at 15:00, 11 hours 40 minutes ago Norsemont Drills 20 Meters of 1.20 G/T Gold Equivalent at Bottom of Hole
Published on 06/05/2026 at 13:30, 13 hours 10 minutes ago CANEX Announces Gold Basin Resources Shareholders Approve Merger Arrangement With CANEX With 75.82% Support
Published on 06/05/2026 at 13:00, 13 hours 40 minutes ago Ur-Energy Reports Results of Annual General and Special Meeting of Shareholders
Published on 06/06/2026 at 00:20, 2 hours 19 minutes ago Guild Wars 3, Modern Evolution of the MMORPG, Announced at Summer Game Fest for PC and PlayStation 5
Published on 06/05/2026 at 23:05, 3 hours 34 minutes ago Quantinuum Announces Closing of Upsized Initial Public Offering
Published on 06/05/2026 at 19:06, 7 hours 33 minutes ago EQS-Adhoc: Brockhaus Technologies AG: The Company's Management Board intends to return approx. €180 million of the proceeds from the sale of the Bikeleasing Group to shareholders
Published on 06/05/2026 at 18:48, 7 hours 52 minutes ago Digital transformation journey takes centre stage at ANGOTIC 2026
Published on 06/05/2026 at 18:32, 8 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/05/2026 at 19:00, 7 hours 40 minutes ago ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 7 hours 40 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 7 hours 40 minutes ago ALTAREIT - Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 7 hours 40 minutes ago ALTAREA : Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 7 hours 40 minutes ago ALTAREIT - DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES MAI 2026
